Home

Compass Therapeutics, Inc. - Common Stock (CMPX)

3.3800
+0.2600 (8.33%)

Compass Therapeutics is a biotechnology company dedicated to developing innovative therapies for cancer and other serious diseases

The company focuses on harnessing the power of the immune system to create novel treatment options that target specific pathways involved in tumor growth and immune response. By employing a combination of advanced technologies and comprehensive research, Compass Therapeutics aims to deliver transformative medicines that improve patient outcomes and address unmet medical needs in oncology. Their pipeline includes a range of therapeutic candidates that are designed to enhance the immune system's ability to fight cancer effectively.

SummaryNewsPress ReleasesChartHistoricalFAQ

Frequently Asked Questions

Is Compass Therapeutics, Inc. - Common Stock publicly traded?
Yes, Compass Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Compass Therapeutics, Inc. - Common Stock trade on?
Compass Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Compass Therapeutics, Inc. - Common Stock?
The ticker symbol for Compass Therapeutics, Inc. - Common Stock is CMPX on the Nasdaq Stock Market
What is the current price of Compass Therapeutics, Inc. - Common Stock?
The current price of Compass Therapeutics, Inc. - Common Stock is 3.380
When was Compass Therapeutics, Inc. - Common Stock last traded?
The last trade of Compass Therapeutics, Inc. - Common Stock was at 4:00 pm EST on February 5th, 2025
What is the market capitalization of Compass Therapeutics, Inc. - Common Stock?
The market capitalization of Compass Therapeutics, Inc. - Common Stock is 430.90M
How many shares of Compass Therapeutics, Inc. - Common Stock are outstanding?
Compass Therapeutics, Inc. - Common Stock has 127.49M shares outstanding.